TABLE 2.

Characteristics of patients who failed antibiotic treatment after at least 56 days of antibiotics in Barwon Health cohort from 1998 to 2018^a

Patient no.	Age (yrs)	Gender	Wt (kg)	WHO stage	Size (mm2)	Lesion type	IS	Atb duration (days)	Atb regimen	Dose reduced	Rif dose (mg/kg)	Clr dose (mg/kg)	Surgery	Site of relapse	Time to relapse (days)	CS	PR
1	1	Male	15	1	100	Nodule	No	56	Rif-Clr	No	10.0	13.3	No	Initial site	100	No	No
2	62	Male	137	1	700	Ulcer	No	56	Rif-Clr	No	4.4	7.3	No	Initial site	175	No	Yes
3	86	Male	99	3	6,630	Ulcer	Yes	84	Rif-Clr	Yes	3.0	5.1	No	Initial site	252	Yes	Yes
4	79	Male	102	2	2,500	Ulcer	No	56	Rif-Clr	Yes	5.9	4.9	No	Local new lesion	175	No	No
5	74	Male	106	2	2,660	Ulcer	Yes	70	Rif-Clr	No	5.7	9.4	No	Initial site	188	Yes	Yes
6	43	Male	95	1	484	Ulcer	No	56	Rif-Clr	No	6.3	10.5	No	Initial site	290	No	No
7	73	Male	112	3	572	Nodule	No	56	Rif-Clr	No	5.4	8.9	No	Initial site	270	No	Yes

^aIS, immune suppression; Rx, treatment; Atb, antibiotic; Rif, rifampin; Clr, clarithromycin; CS, corticosteroids; PR, paradoxical reaction.